Reactive Oxygen Species in Cardiometabolic Syndrome, Neuronal Diseases and Cancer Reactive Oxygen Species in Cardiometabolic Syndrome, Neuronal Diseases and Cancer

Reactive Oxygen Species in Cardiometabolic Syndrome, Neuronal Diseases and Cancer

From Bench to its Potential Therapeutics

    • USD 179.99
    • USD 179.99

Descripción editorial

Reactive Oxygen Species in Cardiometabolic Syndrome, Neuronal Diseases and Cancer: From Bench to its Potential Therapeutics systematically summarizes findings concerning the biochemical properties of various reactive oxygen species (ROS). The book opens with foundational coverage of ROS, ROS signaling, as well as the role of ROS in controlling gene expression. Subsequent chapters cover molecular mechanisms of ROS, regulation of gene expression, and antioxidant supplementation with cardiometabolic syndrome, various neuronal diseases, and cancer. It concludes with recent findings on therapeutic modulations of intracellular levels of ROS, which may significantly impact the development of novel agents for treating the conditions covered.This is a must-have reference for scientists and medical professionals seeking to enhance their knowledge of ROS research and the impact on treatments for cardiometabolic syndrome, neuronal diseases, and cancer.

- Provides a foundation on reactive oxygen species (ROS), ROS signaling, and regulation of gene expression

- Presents an overview of the molecular mechanisms of ROS in reactive oxygen species in cardiometabolic syndrome, specific neural diseases, and cancer

- Reviews recent findings on ROS and regulation of gene expression

- Covers the effects of antioxidant supplementation

GÉNERO
Ciencia y naturaleza
PUBLICADO
2025
5 de agosto
IDIOMA
EN
Inglés
EXTENSIÓN
500
Páginas
EDITORIAL
Elsevier
VENDEDOR
Elsevier Ltd.
TAMAÑO
10.8
MB